Summary of subjective treatment emergent adverse events (TEAE), overall and by study arm.
TEAE, TEAEs
Frequencies reflect the number of individuals reporting each AE term, regardless of the number of times that AE term was reported by the individualBased on results of multivariable analyses, there were no differences in TEAE after adjusting for age, sex, BMI category, treatment arm, baseline abnormality or baseline Mf count.Overall, 8.5% of participants experienced a grade 2 TEAE, and TEAEs did not differ significantly between groups, occurring in 3/42 (7.3%) after IA, 1/40 (2.5%) after MoxA, 6/41 (14.6%) after IDA, and 4/42 (9.5%) after MoxDA (p = 0.267). Most grade 2 TEAEs had resolved by day 7. One person was lost to follow up and 2 with persistence at 7 days had resolution at the time of a repeat visit later in the study).